Orion - Decisions of general meeting

Orion Corporation: Decisions by the AGM on 31 March 2011

Orion Corporation       Stock Exchange Release   31 March 2011     at 4.15 p.m.
EEST


Orion Corporation: Decisions by the AGM on 31 March 2011

At the Annual General Meeting of Orion Corporation held today, the following
decisions were made:
  * A dividend of EUR 1.20 per share was confirmed to be paid for 2010.
    Additionally, EUR 0.06 per share was confirmed to be paid to the
    shareholders as a repayment of capital. The record date for the dividend
    payment and the repayment of capital is 5 April 2011 and the payment date is
    12 April 2011.
  * The proposals concerning the election and remuneration of the Board of
    Directors and the auditor, and the reduction of the share premium fund were
    approved.
  * Sirpa Jalkanen, Eero Karvonen, Matti Kavetvuo, Hannu Syrjänen, Heikki
    Westerlund and Jukka Ylppö were re-elected to the Board of Directors. Hannu
    Syrjänen was re-elected as Chairman.


The Annual General Meeting of Orion Corporation was held today in Helsinki. The
following matters were handled at the meeting:

Adoption of the Financial Statements for 1 January - 31 December 2010
The AGM confirmed the Financial Statements of the parent company and the Group
as per 31 December 2010.

Dividend EUR 1.20 per share
A dividend of EUR 1.20 per share was approved for 2010. The record date for the
dividend payment is
5 April 2011 and the payment date is 12 April 2011.

EUR 0.06 per share as a repayment of capital
EUR 0.06 per share was decided to be distributed to the shareholders from the
Expendable fund in the distributable equity as a repayment of capital. The
record date for the repayment is 5 April 2011 and the payment date is 12 April
2011.

Discharge from liability
The members of the Board of Directors and the President were discharged from
liability for the financial period of 1 January - 31 December 2010.

Remunerations to be paid to the Board of Directors
As an annual fee for the term of office of the Board of Directors, the Chairman
shall receive EUR 72,000, the Vice Chairman shall receive EUR 49,000 and the
other members shall receive EUR 36,000 each. As a fee for each meeting attended,
the Chairman shall receive EUR 1,200, the Vice Chairman shall receive EUR 900
and the other members shall receive EUR 600 each. In accordance with previously
adopted practice, the travel expenses of all Board members shall be paid in
accordance with the travel policy of the company. The afore-mentioned fees shall
also be paid to the Chairmen and to the members of the committees established by
the Board, for each committee meeting attended.

Of the annual fee, 60% shall be paid in cash and 40% in Orion Corporation B-
shares, which shall be acquired to the members during 4-8 April 2011 from the
stock exchange in amounts corresponding to EUR 28,800 for the Chairman, EUR
19,600 for the Vice Chairman and EUR 14,400 for each of the other members. The
part of the annual fee that is to be paid in cash corresponds to the approximate
sum necessary for the payment of the income taxes on the fees and shall be paid
no later than 29 April 2011. The annual fees encompass the full term of office
of the Board of Directors.

Board of Directors re-elected in the previous composition.
Hannu Syrjänen re-elected as Chairman
The number of members in the Board of Directors was confirmed to be six. Sirpa
Jalkanen, Eero Karvonen, Matti Kavetvuo, Hannu Syrjänen, Heikki Westerlund and
Jukka Ylppö were re-elected to the Board of Directors for the next term of
office. Hannu Syrjänen was re-elected as Chairman.

Auditor and their remuneration
PricewaterhouseCoopers Oy, Authorised Public Accountant Firm, was re-elected as
the company's Auditor for the next term. The remuneration of the auditor shall
be based on invoicing as approved by the company.

Reduction of the share premium fund in the Balance Sheet
The share premium fund in Orion Corporation's Balance Sheet on 31 December 2010
was decided to be reduced by EUR 17,797,958.60 by transferring all the share
premium assets into the reserve for invested unrestricted equity.


The minutes of the AGM will be provided in Finnish only, and they will become
available on Orion's internet website, address www.orion.fi/agm2011, no later
than 14 April 2011.

Orion Corporation

Timo Lappalainen                   Olli Huotari
President and CEO                 SVP, Corporate Functions


Contact person:
Terhi Ormio, VP, Communications, phone +358 50 966 4646


Publisher:
Orion Corporation
Communications
Orionintie 1A, 02200 Espoo
Homepage: www.orion.fi


Orion is an innovative European R&D-based pharmaceutical and diagnostic company
with a special emphasis on developing medicinal treatments and diagnostic tests
for global markets. Orion develops, manufactures and markets human and
veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic
tests. Orion's pharmaceutical R&D focuses on the following core therapy areas:
central nervous system drugs, cancer and critical care drugs, and Easyhaler(®)
pulmonary drugs.

The Group's net sales in 2010 amounted to approximately EUR 850 million. The
Company invested EUR 85 million in research and development. At the end of
2010, the Group had a total of approximately 3,100 employees, of whom 2,450
worked in Finland and 650 in other European countries. Orion's A and B shares
are listed on NASDAQ OMX Helsinki.


[HUG#1502222]